Overview


The Antimicrobial Susceptibility Testing (AST) Market is focused on products and tools used to assess the effectiveness of antibiotics and other antimicrobials against pathogens. It includes automated systems, manual kits, culture media, and diagnostic tools utilized by hospitals and labs for informed treatment decisions.

According to FutureWise analysis, the European Antimicrobial Susceptibility Testing market in 2026 is US$4.85 billion and is expected to reach US$7.51 billion by 2036, at a CAGR of 4.47%. The European Antimicrobial Susceptibility Testing (AST) market is experiencing significant growth due to the increasing prevalence of antimicrobial resistance (AMR) and the rising demand for rapid and accurate diagnostic tools. The market is further bolstered by the growing adoption of automated and molecular-based AST technologies, as well as supportive government initiatives aimed at strengthening infection control measures. Additionally, the rise in healthcare spending and the focus on personalized medicine are expected to create substantial opportunities for key players in the region. 

Growth Drivers:

  • Rising cases of antimicrobial resistance (AMR) worldwide
  • Increasing prevalence of infectious diseases
  • Growing demand for rapid and accurate diagnostic testing
  • Advancements in automated and AI-based laboratory systems
  • Higher healthcare spending and improved lab infrastructure

Key Trends:

  • Shift toward rapid and point-of-care susceptibility testing
  • Integration of AI and advanced data analytics for faster results
  • Increased adoption of automated and high-throughput systems
  • Growing use of molecular and genomic testing techniques
  • Expansion of cloud-based and connected diagnostic platforms

Market Segmentation and Key Players:

The Antimicrobial Susceptibility Testing Market is segmented by product (automated instruments, manual test kits, culture media, and consumables), method (dilution, disk diffusion, E-test, automated and molecular/genotypic methods), type (antibacterial, antifungal, and others), application (clinical diagnostics, drug discovery, epidemiology), and end user (hospitals & diagnostic labs, pharmaceutical & biotech companies, research institutes). The market is analyzed across major regions, including North America, Europe, Asia-Pacific, and others. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Antimicrobial Susceptibility Testing Market include bioMérieux, BD (Becton, Dickinson and Company), and Thermo Fisher Scientific.

Research Methodology:

The Antimicrobial Susceptibility Testing Market research methodology by FutureWise Research combines secondary research (industry reports, company annual reports, government publications, and databases) with primary research (interviews with key industry experts and stakeholders). The study uses data triangulation and market modeling techniques to estimate market size, analyze segment-wise performance, and forecast future growth trends. This approach ensures accurate insights into market dynamics, competitive landscape, and regional analysis.

  • BioMérieux
  • BD
  • Danaher
  • Thermo Fisher
  • Bio-Rad Laboratories
  • Hi-Media
  • Merlin
  • Liofilchem
  • Accelerate
  • Alifax
  • Creative Diagnostics
  • Merck Group
  • Synbiosis
  • Bioanalyse
  • Zhuhai DL Biotech.

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in Antimicrobial Susceptibility Testing Market:

BioMérieux

  • VITEK REVEAL has been introduced as an innovative rapid phenotypic antimicrobial susceptibility testing (AST) system, specifically designed for positive blood cultures, providing results in approximately 3 to 6 hours.
  • Additionally, the VITEK COMPACT PRO has received FDA clearance, reflecting its status as an updated identification and AST platform with enhanced performance capabilities.
  • bioMérieux (France) launched its automated microbiology middleware, MAESTRI,A in early 2023, streamlining lab workflows and enhancing accuracy in AST data management

BD

  • Enhanced its Phoenix™ M50 automated ID/AST system with new regulatory approvals. Encountered supply chain issues in blood culture media, affecting some clinical laboratories.
  • BD (Becton, Dickinson & Co.) furthered its collaboration with Accelerate Diagnostics (US) by integrating Accelerate’s rapid testing platforms into its global offering, cutting susceptibility result times from days to hours.

Thermo Fisher

  • Thermo Fisher Scientific (US) continues to expand its portfolio: its Sensititre AST platform has been updated to support newer agents, such as cefiderocol and imipenem/sulbactam, while earlier launches, like the ARIS HiQ system, have further improved automated MIC result accuracy.

 

  • In May 2022, NanoSynex Ltd., a company in which Qualigen recently finalized arrangements to acquire controlling ownership, was highlighted at BioMed Israel, according to an announcement from Qualigen Therapeutics. Innovative technology developed by NanoSynex aims to six-fold accelerate the turnaround time for antimicrobial susceptibility test results.

The antimicrobial susceptibility testing (AST) market is dynamic and is influenced by various factors, such as the prevalence of infectious diseases, technological advancements, and government initiatives. One of the key factors driving the growth of the AST market is the rising prevalence of infectious diseases globally. The emergence of new strains of drug-resistant bacteria and the increasing use of antibiotics has increased the demand for AST products and services. The development of new and advanced technologies is also driving the growth of the AST market. Advances in proteomics and genomics have led to the development of new diagnostic tools that can quickly and accurately identify pathogens and their resistance mechanisms. This has resulted in improved patient outcomes and reduced healthcare costs. Government initiatives and policies are also playing a critical role in the growth of the AST market. Several governments worldwide have implemented programs to promote the rational use of antibiotics and prevent the spread of antibiotic-resistant infections. These initiatives have led to increased demand for AST products and services.

However, the high cost of AST products and services remains a major challenge for the market. The high cost of these products and services limits their accessibility, particularly in low-income countries with a high burden of infectious diseases. Moreover, the lack of standardization in AST procedures and the emergence of new resistance mechanisms pose significant challenges for the market. Developing standardized testing procedures and implementing quality control measures are essential to ensure accurate and reliable results.

Overall, the AST market is dynamic, and it is anticipated to expand throughout the forecast period due to the rising prevalence of infectious illness, the development of new and innovative technologies, and government initiatives to promote the rational use of antibiotics. However, the market faces significant challenges that must be addressed to ensure its growth and sustainability.

By Product

  • Automated Laboratory Instruments
  • Manual Antimicrobial Susceptibility Testing Products
    •    Susceptibility Testing Disks
    •    MIC Strips
    •    Susceptibility Plates
  • Culture and Growth Media
  • Consumables

By Method

  • Dilution
  • Disk Diffusion
  • ETEST
  • Automated Antimicrobial Susceptibility Testing
  • Genotypic Methods

By Type

  • Antibacterial Testing
  • Antifungal Testing
  • Antiparasitic Testing
  • Other Susceptibility Testing

By Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Other Applications

By End User

  • Diagnostic Centers and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Research and Academic Institutes 

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

Here’s a regional view of where the most progress is happening

The most significant activity and innovations are concentrated in North America and Europe

North America (U.S., especially)

  • Most FDA 510(k) clearances in 2024–2025 (bioMérieux VITEK REVEAL, Accelerate Arc, BD Phoenix upgrades) will occur in the U.S.
  • Clinical Need: Consistent monitoring of high rates of antimicrobial resistance, robust hospital networks, and increased funding for stewardship programs.

Europe

  • ESCMID/ECCMID, the largest infectious diseases and microbiology meetings in Europe, serve as major launchpads for innovations in antimicrobial susceptibility testing (AST).
  • "Players in the market include bioMérieux from France, Roche Diagnostics from Switzerland, Siemens Healthineers from Germany, and Beckman Coulter, which has a presence in the EU."

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share of 35% in the global market in 2022. One of the main reasons is the high prevalence of infectious diseases in this region, which has created a significant demand for AST products and services. In addition, North America has a well-established healthcare infrastructure and a strong focus on research and development in the field of healthcare. This has led to the development of advanced technologies and innovative products in the AST market, further boosting the demand for these products. Moreover, the presence of key market participants in the AST market, such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Becton, Dickinson and Company, among others, has also contributed to the dominance of this region in the market. Additionally, based on end-user; the hospitals and diagnostic center segment accounted for the majority revenue share, and based on product type; the automated instruments segment is predicted to grow with the highest CAGR. Furthermore, at FutureWise, we also offer customization in the region segment based on your requirements. Kindly, share your requirement at


  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antimicrobial Susceptibility Testing Market By Product, By Method, By Type, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antimicrobial Susceptibility Testing Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antimicrobial Susceptibility Testing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antimicrobial Susceptibility Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antimicrobial Susceptibility Testing Market, By Product Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Automated Laboratory Instruments
        2. Manual Antimicrobial Susceptibility Testing Products
         2.1. Susceptibility Testing Disks
         2.2. MIC Strips
         2.3. Susceptibility Plates
        3. Culture and Growth Media
        4. Consumables

  • 8.   Antimicrobial Susceptibility Testing Market, By Method Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Dilution
        2. Disk Diffusion
        3. ETEST
        4. Automated Antimicrobial Susceptibility Testing
        5. Genotypic Methods

  • 9.   Antimicrobial Susceptibility Testing Market, By Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Antibacterial Testing
        2. Antifungal Testing
        3. Antiparasitic Testing
        4. Other Susceptibility Testing

  • 10.   Antimicrobial Susceptibility Testing Market, By Application Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Clinical Diagnostics
        2. Drug Discovery and Development
        3. Epidemiology
        4. Other Applications

  • 11.   Antimicrobial Susceptibility Testing Market, By End User Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Diagnostic Centers and Hospitals
        2. Pharmaceutical and Biotechnology Companies
        3. Contract Research Organizations (CROs)
        4. Research and Academic Institutes

  • 12.   North America Antimicrobial Susceptibility Testing Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 13.   Latin America Antimicrobial Susceptibility Testing Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 14.   Europe Antimicrobial Susceptibility Testing Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 15.   Asia Pacific Antimicrobial Susceptibility Testing Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 16.   Middle East and Africa Antimicrobial Susceptibility Testing Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. bioMérieux
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BD
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Danaher
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hi-Media
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. MERLIN
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Liofilchem
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Accelerate
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Alifax
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Creative Diagnostics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Merck Group
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Synbiosis
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Bioanalyse
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Zhuhai DL Biotech
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

FAQ


Antimicrobial Susceptibility Testing is a laboratory procedure used to determine the effectiveness of antibiotics against specific pathogens. It guides clinicians in choosing the most appropriate antibiotic treatment for infections, thereby ensuring effective patient care and combatting antibiotic resistance.

Key trends in the market include advancements in rapid testing methods, an increased focus on multidrug-resistant organisms, and the integration of artificial intelligence to predict antimicrobial resistance patterns. Our report explores these trends in depth, providing data-backed insights into their implications for the market.

The Antimicrobial Susceptibility Testing research report contributes valuable data on the existing resistance patterns and the effectiveness of current antibiotics. This information is vital for pharmaceutical companies and researchers in the development of new treatments that are needed to combat resistant strains of microorganisms.

Antimicrobial susceptibility testing and antibiotic sensitivity testing are terms that are often used interchangeably since they both refer to the process of assessing the susceptibility of bacteria to various antimicrobial agents. However, antimicrobial susceptibility testing is a broader term that includes testing against a range of antimicrobial agents, including antifungals, antivirals, and antiparasitics, whereas antibiotic sensitivity testing specifically refers to testing the efficacy of antibiotics against bacteria.

The Antimicrobial Susceptibility Testing Market Report offers valuable insights on market trends, new technologies, and investment opportunities. It helps diagnostic labs, pharmaceutical firms, and healthcare providers make informed decisions on resource allocation, R&D strategies, and collaborations in this sector.

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

Related Market

Antiviral and Antimicrobial Coatings Market

Read More

Antifungal Treatment Market

Read More

Antibacterial Coatings Market

Read More

Antimicrobial Suture Market

Read More

Veterinary Antimicrobial Susceptibility Testing Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11